Fundraising Fox네오켄바이오
1 known investors
Find your way into 네오켄바이오
Sign up to see every warm intro you have to 네오켄바이오
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 네오켄바이오 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeoCannBio is a technology spin-off from KIST developing cannabinoid-based pharmaceuticals and producing hemp-derived cannabinoid drug ingredients, including high-purity CBD via microwave processing and GMP production. The company builds a broad cannabinoid library and develops new drugs for patients with rare and intractable diseases in Korea.
Investors · 1
Frequently asked questions
- What does 네오켄바이오 do?
- NeoCannBio is a technology spin-off from KIST developing cannabinoid-based pharmaceuticals and producing hemp-derived cannabinoid drug ingredients, including high-purity CBD via microwave processing and GMP production. The company builds a broad cannabinoid library and develops new drugs for patients with rare and intractable diseases in Korea.
- Who are 네오켄바이오's investors?
- 네오켄바이오's investors include Hyundai Venture Investment Corporation.